Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Condition:   Acne Vulgaris Interventions:   Drug: Clindamycin Phosphate;   Drug: Clindamycin Phosphate RLD;   Drug: Placebos Sponsor:   Taro Pharmaceuticals USA Completed

Source: ClinicalTrials.gov - March 25, 2020 Category: Research Source Type: clinical trials